Publication Date

2011

Journal

The Texas Heart Journal

PMID

21720462

Publication Date(s)

2011

Language

English

PMCID

PMC3113132

PubMedCentral® Posted Date

2011

PubMedCentral® Full Text Version

Post-Print

Published Open-Access

yes

Keywords

Animals, Antineoplastic Agents, Cardiology, Cooperative Behavior, Delivery of Health Care, Integrated, Heart, Heart Diseases, Humans, Interdisciplinary Communication, Medical Oncology, Myocytes, Cardiac, Patient Care Team, Prognosis, Risk Assessment, Risk Factors

Abstract

Onco-cardiology is an evolving discipline that requires the consideration of cardiotoxicity in preclinical, clinical,and therapeutic aspects of protocol development,treatment, and surveillance of patients who have undergone interventions using cardiotoxic agents. Only then can we foster new ways to maximize survival while keeping cardiac damage within acceptable limits. It is to this end that our working together has brought us to our present understanding. In the future, we may expect onco-cardiology to play an even greater role in the care of cancer patients.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.